Molecular Devices, a subsidiary of Danaher Corporation, is a leading provider of innovative solutions in the life sciences, diagnostics, and biotechnology sectors. The company is dedicated to accelerating scientific discovery and improving lives through its advanced automated and AI-enabled technologies. With a strong focus on collaboration, authenticity, and innovation, Molecular Devices empowers researchers in academia, biotech, pharma, and government to tackle complex scientific questions and develop safer, more effective therapeutics. The company fosters a culture of belonging and continuous improvement, ensuring that every team member's unique perspective contributes to groundbreaking advancements in science and technology. Committed to diversity and inclusion, Molecular Devices aims to make a tangible impact on global health and well-being.